We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Theranos for President?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Ethics > Theranos for President?
DiagnosticsMedical EthicsMedical InnovationsNewsPublic HealthTechnology

Theranos for President?

etwilson
etwilson
Share
5 Min Read
SHARE

In the health tech universe, function lags hype by a huge margin.

That seems to be the lesson being taught over and over again, as the promised benefits and game-changing impact of new technologies, systems, and capabilities remain as elusive as ever, even while the crowd of innovators continues to grow.

In the health tech universe, function lags hype by a huge margin.

That seems to be the lesson being taught over and over again, as the promised benefits and game-changing impact of new technologies, systems, and capabilities remain as elusive as ever, even while the crowd of innovators continues to grow.

More Read

Hospitals Push Hard for Medicaid Expansion
What Paul Krugman Doesn’t Know About Health Reform
End-of-Life Care? Maybe
Raise Medicare Age? That’s Cost Shifting, Not Cost Saving
Vaccines in the Pipeline and Vaccine Economics

Theranos (and it’s CEO Elizabeth Holmes) is, if not the latest, then certainly the largest single hype machine to slowly dissolve under scrutiny.

It is hard not to notice, in an election year, the similarities of Theranos’ trajectory and that of the typical presidential candidate. Much as America’s executive hopefuls make the usual gestures of guaranteeing change, progress, prosperity, and security, Theranos has joined the crowd of health technology innovators heralding its proprietary vision of the future as the surest way forward for everyone.

But while an overhyped presidential candidate can, at worst, be censured by the four-year term limits and election cycle, there may be no coming back from an errant diagnosis or the expense of unnecessary care. That is why it is so destructive to see that although Theranos promised to turn the blood-testing industry on its head, a series of investigative reports have shown the hype to be mostly just that: hype.

Theranos may yet prove its methods and devices and justify the great acclaim and wealth it has thus far attracted. The more important outcome in the shorter term is that compelling stories not be allowed to substitute for diligent scrutiny. Presidential elections are taxing enough; we don’t need the same sort of cult-like phenomenon driving the advance of medical science.

To a disheartening extent, a similar approach was taken—and federally endorsed—with respect to Electronic Health Records (EHR). The heralded benefit to doctors and patients, personalized care and population health, accountable care and quality tracking, all came well in advance of broadly demonstrated and duplicable outcomes. Interoperability standards came too late (in fact, they are still en route) relative to the mandated adoption of EHR platforms.

The net result is that stakeholders are both bullish and bearish when it comes to measuring progress and navigating disruption.

“It is coming faster than some people thought it would come, and slower and on a more complicated basis than others have also predicted,” explained Professor Carl Nelson in a presentation on the future of healthcare at Northeastern University.

When expectations are set according to the loudest fanfare, rather than carefully aligned with transparent, studied outcomes, the state of the industry will, paradoxically, end up showing us as being both ahead, and behind.

The spectacular potential of new technology—presented by the HITECH reforms and driving adoption alongside innovation in the HIT field—deserves continued emphasis; but it also warrants cautious skepticism.

“It’s something we may have to just live with,” Nelson concludes. “The benefits may outweigh these costs. But the trend to focus on EMRs and interoperability will continue, and should continue cautiously.”

Many an individual is crippled by healthcare costs, insurance or no. That the public, the media, and professionals across a spectrum of stakeholder industries (finance, commercial, and yes, even medical) are so readily enraptured by a good story without demanding hard data to back it up is alarming, disquieting, and ultimately, expensive both in dollars and in credibility. Populism and cults of personality may be dominant forces in American politics, but American healthcare is in the midst of a critical transition: expectations and accountability deserve to be higher.

As with Theranos, the promise of EHRs may well be delivered upon in the future; now, however, trial and error rules the day. The potential of technology must still be buttressed by the human-based systems of the past, before it can be fulfilled.

Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

The Nervous System Reset Guide: Simple Ways To Manage Stress -- AI-generated illustration
The Nervous System Reset Guide: Simple Ways To Manage Stress
Infographics Mental Health
November 14, 2026
Flat editorial illustration: A single digital quality-management platform connects document control, electronic approval, audit r
6 Best QMS Software Platforms for ISO 13485 and FDA Part 820 (QMSR)
Global Healthcare Policy & Law
November 12, 2026
Flat editorial illustration: Healthcare editorial illustration about accurate patient intake connecting registration, clinical re
The Role of Patient Data Accuracy in Healthcare Operations
Global Healthcare Policy & Law
November 11, 2026
Flat editorial illustration: Healthcare ethics-and-law training, shown through a coached clinical role-play where structured disc
Medical Ethics and the Law: The Training Behind Professionals Who Resolve Healthcare Disputes
Uncategorized
November 6, 2026

You Might also Like

Why One-Size-Fits-All-Medicine Doesn’t Work

April 6, 2012

Deleted

October 5, 2014
Hemostat-number-companies-2012
BusinessMedical Devices

The Undeniable Hemostasis Opportunity

May 2, 2012
Medical Ethics

Medical Ethics: Why I Wouldn’t Write a Prescription

October 8, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?